Pharmaceutical Executive Issue Alert Having trouble viewing this email? Click here
Web Version | Share with a colleague | View Digital Edition | Subscribe
In our May issue of Pharmaceutical Executive
FEATURES

Cover Story
 Dollars and Digital: The Future of Pharma Finance
 Lisa Henderson
In this roundtable, pharma and biotech finance leaders discuss the pace of digital technology adoption in accounting and reporting, and the growing recognition of data and analytics in delivering deeper business insights across the organization.
Download the digital issue
 
 
Finance
The CFO Evolution
 Julian Upton
Interviews spotlighting the changing dynamics for C-suite business managers in two contrasting life sciences settings–big, established pharma and small, aggressive biotech.
Download the digital issue
ADVERTISEMENT
AI-powered Biomedical Literature Discovery supporting Science-based Business Decisions
Tuesday, May 21, 2019 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register Now
Finance
Impact Investing and R&D
 Joseph Constance
Private equity investment and venture capital have long spurred R&D efforts for hard-to-treat conditions. Joining the mix of late has been impact investing and the opportunities for the socially-conscious to influence drug development–and reap potential benefits in health outcomes and financial return.
Download the digital issue
Opinion
It's Time for a Chief Adherence Officer
 Tom Kottler
The best way to capitalize on the potential revenue influx from enterprise-level drug adherence programs is to create room at the executive table for a Chief Adherence Officer.
Download the digital issue
Back Page
Adopting New Technology: Barriers and Breakthroughs
 Chrissy Bell
Preserving positive ROI amid healthcare's innovation explosion.
Download the digital issue

ALSO IN THIS ISSUE
 We've Got You Covered
Lisa Henderson
With conference season in high gear, here's the lowdown on our content highlights so far from the event circuit and what to expect on horizon  …Read more

FDA After Gottlieb: Thorny Issues, Political Challenges
Jill Wechsler
New leadership faces a host of complex initiatives to promote innovation and protect public health  …Read more

New Flare-Up in Europe's External Reference Pricing Debate
Reflector
European industry fights over every inch on comparative drug pricing initiative  …Read more

 
WEBCASTS
AI-powered Biomedical Literature Discovery supporting Science-based Business Decisions
Patient Adherence: A Hard Pill to Swallow?
Using Real-World Evidence for U.S. Regulatory Decision-Making: What Pharma Needs to Know
Japan Market Entry: How to Navigate the Clinical Development Regulatory Environment and Best Methods to Utilize Opportunities
Patient Assistance Centers of Excellence: The Next Generation of Brand Support
Bringing Intelligence to Drug Discovery—The Importance of Contextual Information at All Levels
Seizing Opportunities in Japan, the Second Largest Innovation-Driven Pharmaceutical Market
 
Download the
issue:
 
image
 

Pharmaceutical Executive is free to qualified subscribers. To subscribe, click here.

Click here to contact the Pharmaceutical Executive sales team.
Twitter LinkedIn